Exclusive: Biogen to name top executive Vounatsos as CEO - sources

(Reuters) - Biogen Inc, the U.S. drug maker focused on neurological, autoimmune and rare diseases, is set to appoint its chief commercial officer, Michel Vounatsos, as its new chief executive officer, according to people familiar with the matter.